Related Experiment Video
Updated: Mar 15, 2026

LINE-1 Methylation Analysis in Mesenchymal Stem Cells Treated with Osteosarcoma-Derived Extracellular Vesicles
Published on: February 1, 2020
[Extracellular vesicles and their role in hematological malignancies]
Andrea Rzepiel1, Nóra Kutszegi1,2, Judit Cs Sági2
1II. Gyermekgyógyászati Klinika, Semmelweis Egyetem, Általános Orvostudományi Kar Budapest, Tűzoltó utca 7-9., 1094.
Extracellular vesicles, including microvesicles and exosomes, are key in cell communication and disease. Research shows their potential as biomarkers for diagnosing and monitoring hematological malignancies.
Area of Science:
- Biochemistry
- Cell Biology
- Oncology
Background:
- Extracellular vesicles (EVs) like apoptotic bodies, microvesicles, and exosomes are produced by all organisms.
- EVs play crucial roles in intercellular communication, immune responses, and angiogenesis in physiological and pathological states.
- Alterations in EVs suggest their potential as diagnostic and prognostic biomarkers.
Purpose of the Study:
- To provide an overview of extracellular vesicle research.
- To focus on the findings related to EVs in hematological malignancies.
- To explore the diagnostic and prognostic value of EVs in these cancers.
Main Methods:
- Literature review focusing on extracellular vesicles.
- Analysis of published research on EVs in hematological malignancies.
- Examination of quantitative and qualitative changes in microvesicles and exosomes.
Main Results:
- Quantitative and qualitative changes in microvesicles and exosomes show potential for diagnostics, prognostics, and minimal residual disease monitoring in hematological malignancies.
- Extracellular vesicles' role in downregulating natural killer cell activity in acute myeloid leukemia is demonstrated.
- Microvesicles are implicated in drug resistance in chronic lymphocytic leukemia.
Conclusions:
- Extracellular vesicles represent a promising area for biomarker development in hematological malignancies.
- Further research into EVs could lead to improved diagnostic and therapeutic strategies for blood cancers.
- EVs are integral to understanding disease mechanisms and monitoring treatment efficacy.
Related Concept Videos
Overview of Exosomes
Stahl et al. discovered exosomes in 1983, but the exosomes were initially considered waste products released from the...
Role of Hematopoietic Growth Factors
Thrombopoietin (TPO), mainly released by the liver,...
Regulation of Hematopoietic Stem Cells
Mesenchymal Stem Cells
Intralumenal Vesicles and Multivesicular Bodies
Metastasis
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...

